71 259

Cited 2 times in

The New Diagnosis-Related Group Reimbursement System and Laboratory Test Quality in Korea: Analysis of External Quality Assessment Results

DC Field Value Language
dc.contributor.author한태화-
dc.date.accessioned2022-09-02T01:16:24Z-
dc.date.available2022-09-02T01:16:24Z-
dc.date.issued2020-05-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/190110-
dc.description.abstractKorea introduced a new diagnosis-related group (NDRG), which is a mixed-bundle reimbursement system. We evaluated the effects of NDRGs on laboratory test quality by analyzing data over three years (2016-2018) from the Korean Association of External Quality Assessment Service (KEQAS). A total of 42 NDRG-participating hospitals (CASE), 84 non-participating similar size-hospitals (CON-1), and 42 tertiary hospitals (CON-2) were included. We assumed the proportion of KEQAS results with a larger than 2 standard deviation index (SDI) to be a bad laboratory quality marker (BLQM). CASE BLQMs were lower than CON-1 BLQMs for more than 2 years in alkaline phosphatase (ALP), alanine aminotransferase (ALT), chloride, glucose, sodium, and total protein, and higher in creatinine. CASE BLQMs were higher than CON-2 BLQMs for more than 2 years in ALP, chloride, creatinine, glucose, lactate dehydrogenase (LDH), phosphorus, potassium, sodium, total calcium, total cholesterol, triglyceride, and uric acid. Mean SDIs for general chemistry tests were not significantly different depending on NDRG participation. However, the NDRG is currently a pilot program that compensates the amount of each institution's reimbursement based on the fee-for-service system, and most participants were public hospitals. Thus, the effects of NDRGs on laboratory test quality should be re-evaluated after the NDRG program has stabilized and more private hospitals are participating.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherMDPI AG-
dc.relation.isPartOfHEALTHCARE-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleThe New Diagnosis-Related Group Reimbursement System and Laboratory Test Quality in Korea: Analysis of External Quality Assessment Results-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentResearch Institute (부설연구소)-
dc.contributor.googleauthorSollip Kim-
dc.contributor.googleauthorYeo-Min Yun-
dc.contributor.googleauthorHyeongsu Kim-
dc.contributor.googleauthorTae-Hyun Um-
dc.contributor.googleauthorJeonghyun Chang-
dc.contributor.googleauthorHojin Jeong-
dc.contributor.googleauthorKun Sei Lee-
dc.contributor.googleauthorSail Chun-
dc.contributor.googleauthorYong-Jun Choi-
dc.contributor.googleauthorJae-Hyeok Heo-
dc.contributor.googleauthorTae-Hwa Han-
dc.identifier.doi10.3390/healthcare8020127-
dc.contributor.localIdA06289-
dc.relation.journalcodeJ03929-
dc.identifier.eissn2227-9032-
dc.identifier.pmid32392746-
dc.subject.keyworddiagnosis-related group-
dc.subject.keywordexternal quality assessment-
dc.subject.keywordquality of laboratory testing-
dc.contributor.alternativeNameHan, Taehwa-
dc.contributor.affiliatedAuthor한태화-
dc.citation.volume8-
dc.citation.number2-
dc.citation.startPage127-
dc.identifier.bibliographicCitationHEALTHCARE, Vol.8(2) : 127, 2020-05-
Appears in Collections:
1. College of Medicine (의과대학) > Research Institute (부설연구소) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.